miR-29a attenuates cardiac hypertrophy through inhibition of PPARδ expression

Si Zhang1,2, Zhongnan Yin3, Fei-Fei Dai1

  • 1Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou City, Henan, Peoples's Republic of China.

Insights

MicroRNA-29a (miR-29a) offers a protective role in cardiac hypertrophy by targeting peroxisome proliferator-activated receptor δ (PPARδ) and atrial natriuretic factor (ANF), suggesting its therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Gene Regulation

Background:

  • Cardiac hypertrophy is a significant risk factor for heart failure, yet its underlying mechanisms are not fully understood.
  • Peroxisome proliferator-activated receptor δ (PPARδ) plays a role in cardiac lipid metabolism.
  • MicroRNAs are emerging as key regulators in cardiovascular disease.

Purpose of the Study:

  • To elucidate the novel molecular cascade involving microRNA-29a (miR-29a), peroxisome proliferator-activated receptor δ (PPARδ), and atrial natriuretic factor (ANF) in cardiac hypertrophy.
  • To investigate the cardioprotective role of miR-29a in isoproterenol hydrochloride-induced cardiac hypertrophy.
  • To assess the therapeutic potential of miR-29a for heart hypertrophy treatment.

Main Methods:

  • Investigated a novel PPARδ-dependent molecular cascade involving miR-29a and ANF.
  • Utilized isoproterenol hydrochloride to induce cardiac hypertrophy in a model system.
  • Assessed the effect of miR-29a on PPARδ and ANF expression and cardiac hypertrophy response.

Main Results:

  • Identified a novel PPARδ-dependent molecular cascade involving miR-29a and ANF that is reactivated in cardiac hypertrophy.
  • Demonstrated that miR-29a exhibits a cardioprotective function by targeting PPARδ and downregulating ANF.
  • Showed that miR-29a reduces isoproterenol hydrochloride-induced cardiac hypertrophy.

Conclusions:

  • miR-29a plays a crucial cardioprotective role in mitigating cardiac hypertrophy.
  • The miR-29a/PPARδ/ANF pathway represents a novel therapeutic target for heart hypertrophy.
  • Further research into miR-29a could lead to new treatments for heart hypertrophy and heart failure.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.4K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
What is Gene Expression?01:42

What is Gene Expression?

Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
196.7K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.4K